
Keywords: NACT; neoadjuvant chemotherapy; pCR; complete pathological response; HER2; human epidermalgrowth factor receptor-2; NCCN; National Comprehensive Cancer Network; LABC; locally advanced breast cancer; M&P; Miller&Payne; DCIS; ductal carcinoma in situ; ER; e